Onconetix, Inc. Goodwill, Foreign Currency Translation Gain (Loss)
Onconetix, Inc. (ONCO) reported Goodwill, Foreign Currency Translation Gain (Loss) of -$99.33 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Other Income
us-gaap:GoodwillForeignCurrencyTranslationGainLoss · last filed 2026-08-13
- Onconetix, Inc. goodwill, foreign currency translation gain (loss) for the quarter ending 2026-06-30 was -$99.33K.
- Onconetix, Inc. goodwill, foreign currency translation gain (loss) for the quarter ending 2026-03-31 was -$211.53K.
- Onconetix, Inc. goodwill, foreign currency translation gain (loss) for the quarter ending 2024-12-31 was -$2.17M.
- Onconetix, Inc. goodwill, foreign currency translation gain (loss) for the quarter ending 2024-09-30 was -$2.36M.
- Onconetix, Inc. goodwill, foreign currency translation gain (loss) for fiscal 2024 was -$804.40K, a 214.74% decline from fiscal 2023.
- Onconetix, Inc. goodwill, foreign currency translation gain (loss) for fiscal 2023 was $701.06K.
| Period end | Goodwill, Foreign Currency Translation Gain (Loss) 3 month | Goodwill, Foreign Currency Translation Gain (Loss) 6 month | Goodwill, Foreign Currency Translation Gain (Loss) 9 month | Goodwill, Foreign Currency Translation Gain (Loss) 12 month | Goodwill, Foreign Currency Translation Gain (Loss) 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | -$99.33K 10-Q · filed 2026-08-13 | -$310.86K derived: sum of 2 quarters · filed 2026-08-13 | |||
| 2026-03-31 | -$211.53K 10-Q · filed 2026-08-13 | ||||
| 2025-12-31 | $3.01M 10-Q · filed 2026-05-13 | ||||
| 2024-12-31 | -$2.17M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | -$4.53M derived: sum of 2 quarters · filed 2026-03-13 | -$4.55M derived: sum of 3 quarters · filed 2026-03-13 | -$804.40K 10-K · filed 2026-03-13 | |
| 2024-09-30 | -$2.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-12-10 | -$2.38M derived: sum of 2 quarters · filed 2024-12-10 | $1.36M 10-Q · filed 2024-12-10 | ||
| 2024-06-30 | -$20.01K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-29 | $3.72M 10-Q · filed 2024-08-29 | |||
| 2024-03-31 | $3.74M 10-Q · filed 2024-05-20 | ||||
| 2023-12-31 | $701.06K 10-K · filed 2025-06-02 | $1.76M 10-K · filed 2024-04-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |